Patent Assignment
Reel/Frame 024920/0556
Assignment of Assignor's Interest
Recorded: 2010-08-31
Pages: 7
Assignors
NORONHA, GLENN
Executed: 2006-11-09
MAK, CHI CHING
Executed: 2006-10-31
CAO, JIANGUO
Executed: 2006-10-31
RENICK, JOEL
Executed: 2006-10-31
MCPHERSON, ANDREW
Executed: 2006-10-31
ZENG, BINQI
Executed: 2006-10-31
PATHAK, VED P.
Executed: 2006-11-13
LOHSE, DANIEL L.
Executed: 2006-11-16
HOOD, JOHN D.
Executed: 2006-11-02
SOLL, RICHARD M.
Executed: 2006-11-10
Assignee
TARGEGEN, INC.
9380 JUDICIAL DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Property
(1)
Use of Bi-Aryl Meta-Pyrimidine Inhibitors of Kinases
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the State of Incorporation from a California Corporation to a Delaware Corporation for the Assignee Previously Recorded on Reel 024920 Frame 0556. Assignor(S) Hereby Confirms the State of Incorporation for Targegen, Inc. to Be a Delaware Corporation.
Jun 22, 2012
From: NORONHA, GLENN; MAK, CHI CHING; CAO, JIANGUO; RENICK, JOEL
To: TARGEGEN, INC.
Reel/Frame 028430/0879 →
Assignment of Assignor's Interest
May 25, 2017
From: TARGEGEN, INC.
To: IMPACT THERAPEUTICS, INC.
Reel/Frame 042512/0179 →
Change of Name
May 25, 2017
From: IMPACT THERAPEUTICS, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 042586/0643 →
Security Interest
Nov 30, 2017
From: IMPACT BIOMEDICINES, INC.
To: LIND SA, LLC, AS COLLATERAL AGENT
Reel/Frame 044572/0660 →
Release of Security Interest
Feb 12, 2018
From: LIND SA LLC, AS COLLATERAL AGENT
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 044904/0628 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 042512 Frame: 0179. Assignor(S) Hereby Confirms the Assignment .
Aug 21, 2019
From: TARGEGEN, INC.
To: IMPACT BIOMEDICINES, INC.
Reel/Frame 050297/0562 →